Strides Pharma Science today reported a consolidated net loss of Rs 4.16 crore for the quarter ended June 30.
The company had posted a net profit of Rs 5.78 crore in April-June 2017, Strides Pharma said in a BSE filing.
Consolidated revenue from operations stood at Rs 663.46 crore for the quarter under review. It was Rs 657.78 crore for the same period a year ago.
Shares of the company were trading at Rs 416.40 per scrip on BSE, up 6.20 per cent from the previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
